0001445499-20-000003.txt : 20200506 0001445499-20-000003.hdr.sgml : 20200506 20200506153758 ACCESSION NUMBER: 0001445499-20-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200506 DATE AS OF CHANGE: 20200506 EFFECTIVENESS DATE: 20200506 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IMPEL NEUROPHARMA INC CENTRAL INDEX KEY: 0001445499 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263058238 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-366411 FILM NUMBER: 20852424 BUSINESS ADDRESS: STREET 1: 201 ELLIOTT AVE. W STREET 2: SUITE 260 CITY: SEATTLE STATE: WA ZIP: 98119 BUSINESS PHONE: 206-568-1466 MAIL ADDRESS: STREET 1: 201 ELLIOTT AVE. W STREET 2: SUITE 260 CITY: SEATTLE STATE: WA ZIP: 98119 D 1 primary_doc.xml X0708 D LIVE 0001445499 IMPEL NEUROPHARMA INC 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA WASHINGTON 98119 206-568-1466 DELAWARE None None Corporation true John D. Hoekman c/o Impel NeuroPharma, Inc. 201 Elliott Ave. W, Suite 260 Seattle WA WASHINGTON 98119 Executive Officer Director Stewart Parker c/o Impel NeuroPharma, Inc. 201 Elliott Ave. W, Suite 260 Seattle WA WASHINGTON 98119 Director Aaron Royston c/o Impel NeuroPharma, Inc. 201 Elliott Ave. W, Suite 260 Seattle WA WASHINGTON 98119 Director Mahendra Shah c/o Impel NeuroPharma, Inc. 201 Elliott Ave. W, Suite 260 Seattle WA WASHINGTON 98119 Director David Allison c/o Impel NeuroPharma, Inc. 201 Elliott Ave. W, Suite 260 Seattle WA WASHINGTON 98119 Director Robert Mittendorff c/o Impel NeuroPharma, Inc. 201 Elliott Ave. W, Suite 260 Seattle WA WASHINGTON 98119 Director Tim Nelson c/o Impel NeuroPharma, Inc. 201 Elliott Ave. W, Suite 260 Seattle WA WASHINGTON 98119 Director Ali Satvat c/o Impel NeuroPharma, Inc. 201 Elliott Ave. W, Suite 260 Seattle WA WASHINGTON 98119 Director John Leaman c/o Impel NeuroPharma, Inc. 201 Elliott Ave. W, Suite 260 Seattle WA WASHINGTON 98119 Executive Officer Diane Wilfong c/o Impel NeuroPharma, Inc. 201 Elliott Ave. W, Suite 260 Seattle WA WASHINGTON 98199 Director Adrian Adams c/o Impel NeuroPharma, Inc. 201 Elliott Ave. W, Suite 260 Seattle WA WASHINGTON 98199 Executive Officer Director Other Health Care Decline to Disclose 06b false 2020-05-04 false true true false 0 5622139 0 5622139 Represents securities offered under an equity incentive plan. false 1 0 0 0 false IMPEL NEUROPHARMA INC /s/ Adrian Adams Adrian Adams President and CEO 2020-05-06